These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 2907712

  • 1. Effect of an original piperazine derivative of tetraline on the adrenergically mediated metabolic responses in cats and rats.
    Bogoslovova T, Staneva-Stoytcheva D.
    Acta Physiol Pharmacol Bulg; 1988; 14(4):55-64. PubMed ID: 2907712
    [Abstract] [Full Text] [Related]

  • 2. Beta-adrenoblocking activity of a new derivative of 2-aminotetraline based on some metabolic responses in cats and rats.
    Bogoslovova T, Staneva-Stoytcheva D.
    Acta Physiol Pharmacol Bulg; 1988; 14(3):39-45. PubMed ID: 2906208
    [Abstract] [Full Text] [Related]

  • 3. Effects of a new 2-piperazinotetralin on alpha-1 and alpha-2 adrenergic receptors in isolated rat vas deferens.
    Mutafova-Yambolieva V, Staneva-Stoytcheva D, Ivanov D.
    Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):291-6. PubMed ID: 2997557
    [Abstract] [Full Text] [Related]

  • 4. Metabolic profile of beta-adrenoceptor-blocking action of befunolol.
    Maruyama Y, Awaji T, Inoue M, Takeo S.
    Arch Int Pharmacodyn Ther; 1991 Jun; 311():73-88. PubMed ID: 1686392
    [Abstract] [Full Text] [Related]

  • 5. [Hypotensive and antihypertensive activity of a newly synthesized derivative of 2-aminotetralin].
    Raĭnova L, Georgieva A, Staneva-Stoĭcheva D.
    Eksp Med Morfol; 1978 Jun; 17(1):37-43. PubMed ID: 25170
    [Abstract] [Full Text] [Related]

  • 6. Effect of catecholamines and adrenergic antagonists on blood glucose, free fatty acids and liver glycogen levels in fed rats.
    Bugajski J, Hano J, Zdebska A.
    Pol J Pharmacol Pharm; 1978 Jun; 30(6):799-818. PubMed ID: 755244
    [Abstract] [Full Text] [Related]

  • 7. Effect of one derivative of 2-aminotetralin on the alpha-adrenergic receptors of isolated vessels.
    Mutafova-Yambolieva V, Staneva-Stoytcheva D.
    Acta Physiol Pharmacol Bulg; 1985 Jun; 11(1):18-25. PubMed ID: 2994366
    [Abstract] [Full Text] [Related]

  • 8. [Biochemical studies of acebutolol-the beta1 specificity of acebutolol (author's transl)].
    Hamada Y, Sato I, Ito K, Kuwabara S, Kojima Y.
    Nihon Yakurigaku Zasshi; 1977 Jul; 73(5):591-6. PubMed ID: 21835
    [Abstract] [Full Text] [Related]

  • 9. [Influence of alpha or beta adrenergic antagonists on catecholamine dependent metabolic effects in pigs].
    Brenner KV, Gürtler H.
    Acta Biol Med Ger; 1981 Jul; 40(12):1759-66. PubMed ID: 6125073
    [Abstract] [Full Text] [Related]

  • 10. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
    Nishimura T, Kita S, Abiko Y.
    J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
    [Abstract] [Full Text] [Related]

  • 11. Metabolic and physiological effects of adrenoceptor agonists and antagonists in the horse.
    Snow DH.
    Res Vet Sci; 1979 Nov; 27(3):372-8. PubMed ID: 44381
    [Abstract] [Full Text] [Related]

  • 12. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998 Nov; 50(3):203-12. PubMed ID: 9861628
    [Abstract] [Full Text] [Related]

  • 13. Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.
    Ikeda H, Moribe S, Sato M, Kotani A, Koshikawa N, Cools AR.
    Eur J Pharmacol; 2007 Jan 12; 554(2-3):175-82. PubMed ID: 17113067
    [Abstract] [Full Text] [Related]

  • 14. Examinations of contribution of bradykinin in the action of dopamine in circulatory system of rats. III. Influence of bradykinin on chosen metabolic effects of dopamine.
    Fiedorowicz R, Moniuszko-Jakoniuk J, Wiśniewski K.
    Arch Immunol Ther Exp (Warsz); 1983 Jan 12; 31(5):761-8. PubMed ID: 6675576
    [Abstract] [Full Text] [Related]

  • 15. Interactions between sympathomimetic agonists and blocking agents: cardiac effects of phenylephrine and isoproterenol.
    Márquez MT, Mikulić LE, Aramendía P.
    Methods Find Exp Clin Pharmacol; 1981 Jan 12; 3(5):283-9. PubMed ID: 7329156
    [Abstract] [Full Text] [Related]

  • 16. Metabolic effects of various beta-adrenoceptor blocking agents in rats and dogs.
    Traunecker W.
    Arzneimittelforschung; 1985 Jan 12; 35(1A):376-82. PubMed ID: 2859032
    [Abstract] [Full Text] [Related]

  • 17. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J, Zhang LF, Han C, Yu GS, Ma J.
    J Gravit Physiol; 1996 Apr 12; 3(1):57-62. PubMed ID: 11539308
    [Abstract] [Full Text] [Related]

  • 18. [Adrenergic mechanisms in the hypotensive action of a piperazine derivative of 2-aminotetralin].
    Mutafova-Iambolieva V, Staneva-Stoĭcheva D.
    Eksp Med Morfol; 1985 Apr 12; 24(1):8-12. PubMed ID: 2992908
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y, Karmazyn M.
    Cardiovasc Res; 1996 Sep 12; 32(3):622-9. PubMed ID: 8881523
    [Abstract] [Full Text] [Related]

  • 20. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ.
    Pol J Pharmacol; 1998 Sep 12; 50(3):213-23. PubMed ID: 9861629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.